Advanced search
Start date
Betweenand

Roger Chammas

CV Lattes GoogleMyCitations ResearcherID ORCID


Secretaria da Saúde (São Paulo - Estado). Coordenadoria de Serviços de Saúde (CSS). Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira (ICESP)  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

Roger Chammas, MD-PhD concluded his studies in Medicine (1988) and got his PhD degree in Biochemistry (1993) at Universidade de São Paulo, while working at the Ludwig Institute for Cancer Research (1989-1993). He specialized in Glycobiology at University of California, San Diego (1994-1997) and was a visiting researcher at Friedrich-Miescher Institute, Basel (1991), Harvard School of Public Health, Boston (1993), Universidade Federal de São Paulo (1998-1999) and Moffitt Cancer Research Center, Tampa (2011-2012). Chammas is presently Full Professor of Oncology at Faculdade de Medicina da Universidade de São Paulo, where he has been working since 2000. Chammas serves as chair of the Center for Translational Research in Oncology, a research unit for both basic and translational cancer research at Instituto do Câncer do Estado de São Paulo, a specialized institute for cancer management and oncology teaching and research associated with Universidade de São Paulo. Chammas serves as academic editor for Plos One and Anais da Academia Brasileira de Ciências. His major interests are in the area of Cancer Biology (Biochemistry and Cancer Cell Biology), focusing in tumor progression, carbohydrate-dependent tumor markers and tumor microenvironment, as targets for combination therapy and molecular diagnostics through imaging in cancers. (Source: Lattes Curriculum)

Research grants
Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers* *Updated July 14, 2018
Most frequent collaborators in research granted by FAPESP
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (8)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications7
Citations65
Cit./Article9.3
Data from Web of Science

LONGO MACHADO, CAMILA MARIA; SOUSA ANDRADE, LUCIANA NOGUEIRA; TEIXEIRA, VERONICA RODRIGUES; COSTA, FABRICIO FALCONI; MELO, CAMILA MORAIS; DOS SANTOS, SOFIA NASCIMENTO; NONOGAKI, SUELY; LIU, FU-TONG; BERNARDES, EMERSON SOARES; CAMARGO, ANAMARIA ARANHA; et al. Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGF beta 1-induced macrophages. CANCER MEDICINE, v. 3, n. 2, p. 201-214, . Web of Science Citations: 18. (98/14247-6, 08/11513-0)

IKEMORI, RAFAEL YAMASHITA; LONGO MACHADO, CAMILA MARIA; FURUZAWA, KARINA MIE; NONOGAKI, SUELY; OSINAGA, EDUARDO; UMEZAWA, KAZUO; DE CARVALHO, MARCELO ALEX; VERINAUD, LIANA; CHAMMAS, ROGER. Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival. PLoS One, v. 9, n. 11, . Web of Science Citations: 17. (09/10857-0, 98/14247-6)

RAMOS CIRILO, PRISCILA DANIELE; DE SOUSA ANDRADE, LUCIANA NOGUEIRA; SILVA CORREA, BRUNA RENATA; QIAO, MEI; FURUYA, TATIANE KATSUE; CHAMMAS, ROGER; FERRAZ PENALVA, LUIZ OTAVIO. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1. BMC CANCER, v. 17, . Web of Science Citations: 2. (98/14247-6, 13/11721-0, 13/25483-4)

DE AGUIAR, RODRIGO BARBOSA; PARISE, CAROLINA BELLINI; TEIXEIRA SOUZA, CAROLINA ROSAL; BRAGGION, CAMILA; QUINTILIO, WAGNER; MORO, ANA MARIA; NAVARRO MARQUES, FABIO LUIZ; BUCHPIGUEL, CARLOS ALBERTO; CHAMMAS, ROGER; DE MORAES, JANE ZVEITER. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, v. 371, n. 2, p. 151-160, . Web of Science Citations: 2. (98/14247-6, 09/18631-1, 13/06120-8)

ONUCHIC, ANA CLAUDIA; MACHADO, CAMILA M. L.; SAITO, RENATA F.; RIOS, FRANCISCO J.; JANCAR, SONIA; CHAMMAS, ROGER. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, . Web of Science Citations: 18. (98/14247-6, 08/00247-8)

CARNACHO, XIMENA; MACHADO, CAMILA LONGO; GARCIA, MARIA FERNANDA; GAMBINI, JUAN PABLO; BANCHERO, AGUSTINA; FERNANDEZ, MARCELO; ODDONE, NATALIA; ZANATTA, DANIELA BERTOLINI; ROSAL, CAROLINA; BUCHPIGUEL, CARLOS ALBERTO; et al. Technetium-99m-or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma. ONCOLOGY, v. 92, n. 4, p. 229-242, . Web of Science Citations: 0. (13/06120-8)

NOVAK‚ E.M.; METZGER‚ M.; CHAMMAS‚ R.; DA COSTA‚ M.; DANTAS‚ K.; MANABE‚ C.; PIRES‚ J.; DE OLIVEIRA‚ AC; BYDLOWSKI‚ SP. Downregulation of TNF-α and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Therapy, v. 10, n. 23, p. 1992-1997, . (99/00322-9, 98/14247-6)

SAITO, RENATA DE FREITAS; TORTELLI, JR., THARCISIO CITRANGULO; JACOMASSI, MAYARA D'AURIA; OTAKE, ANDREIA HANADA; CHAMMAS, ROGER. Emerging targets for combination therapy in melanomas. FEBS Letters, v. 589, n. 22, SI, p. 3438-3448, . Web of Science Citations: 8. (13/06120-8)

Patent applications

MOLÉCULA HÍBRIDA PARA DIAGNÓSTICO E /OU PROGNÓSTICO DE DOENÇAS CRÔNICO-DEGENERATIVAS, INFECCIOSAS E DO DESENVOLVIMENTO PI0501095-0 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Universidade de São Paulo (USP). Roger Chammas; Fabiana Henriques Machado de Melo; Diego Alberto Butera Wadsworth; Ana Maria Moura da Silva - February 2005, 24

Distribution map of accesses to this page
Click here to view the access summary to this page.
Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: